tiprankstipranks
DarioHealth Corp (DRIO)
NASDAQ:DRIO
US Market

DarioHealth (DRIO) Earnings Dates, Call Summary & Reports

Compare
263 Followers

Earnings Data

Report Date
May 20, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.1
Last Year’s EPS
-0.2
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 10, 2025
|
% Change Since: -15.07%
|
Next Earnings Date:May 20, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, successful product integration, and a solid financial position, indicating positive momentum for DarioHealth. However, the dependency on future client acquisition for profitability and the absence of full-suite integrated sales were notable challenges. Overall, the positive aspects outweighed the lowlights.
Company Guidance
During DarioHealth's fourth quarter 2024 results call, CEO Erez Raphael highlighted the company's strong financial and business performance, marking significant growth and strategic shifts. The company reported a total revenue of $27 million for 2024, a 32.9% increase from the previous year, with fourth-quarter revenue growing over 110% compared to Q4 2023. The B2B2C segment experienced approximately 400% year-over-year recurring revenue growth, with 35% of this growth attributed to organic expansion. The gross profit for the B2B2C business increased from 51% to 72%, and operating expenses were reduced by 35% from Q1 to Q4 2024. DarioHealth completed a $25.6 million capital raise in January 2025, ending the year with a proforma cash balance of $34.5 million. The company aims to achieve operational cash flow breakeven by the end of 2025, with a further 20% reduction in operating expenses anticipated by Q4 2025. Raphael also emphasized the success of their GLP-1 companion model, contributing significantly to new client wins, and the strategic integration of AI to enhance operational efficiency, member engagement, and customer value.
Record-Breaking Revenue Growth
DarioHealth reported a total revenue of $27 million for 2024, marking a 32.9% increase from $20.4 million in 2023. The B2B2C employers and health plans recurring revenue grew by approximately 400% year-over-year.
Successful Integration of Twill
The acquisition and integration of Twill strengthened DarioHealth's position, creating a comprehensive clinically integrated digital health platform supporting five chronic conditions.
Strong Financial Position
DarioHealth raised $25.6 million in January 2025, with a proforma cash balance of $34.5 million as of December 31, 2024, allowing continued strategic execution.
High Client Renewal Rate
The company maintained a client renewal rate above 90%, reflecting strong value and impact of its platform.
Expansion in the GLP-1 Market
DarioHealth's GLP-1 companion model secured 10 new client wins in 2024, indicating significant demand for comprehensive solutions addressing obesity and metabolic health.
---

DarioHealth (DRIO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DRIO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 20, 20252025 (Q1)
-0.10 / -
-0.2
Mar 10, 20252024 (Q4)
-0.33 / -0.08
-0.4180.49% (+0.33)
Nov 07, 20242024 (Q3)
-0.22 / -0.25
-0.4948.98% (+0.24)
Aug 08, 20242024 (Q2)
-0.45 / -0.08
-0.5886.21% (+0.50)
May 15, 20242024 (Q1)
-0.29 / -0.20
-0.4555.56% (+0.25)
Mar 28, 20242023 (Q4)
-0.39 / -0.41
-0.422.38% (+0.01)
Nov 02, 20232023 (Q3)
-0.52 / -0.49
-0.6423.44% (+0.15)
Aug 10, 20232023 (Q2)
-0.51 / -0.58
-0.7421.62% (+0.16)
May 11, 20232023 (Q1)
-0.50 / -0.45
-0.7439.19% (+0.29)
Mar 09, 20232022 (Q4)
-0.61 / -0.42
-1.1964.71% (+0.77)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

DRIO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 10, 2025$0.73$0.67-8.22%
Nov 07, 2024$0.96$0.97+1.04%
Aug 08, 2024$0.93$0.83-10.75%
May 15, 2024$1.73$1.85+6.94%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does DarioHealth Corp (DRIO) report earnings?
DarioHealth Corp (DRIO) is schdueled to report earning on May 20, 2025, TBA Not Confirmed.
    What is DarioHealth Corp (DRIO) earnings time?
    DarioHealth Corp (DRIO) earnings time is at May 20, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DRIO EPS forecast?
          DRIO EPS forecast for the fiscal quarter 2025 (Q1) is -0.1.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis